Editor’s note: The video recording is embedded below.
The need to respond to the coronavirus pandemic is forcing technology-enabled change in health care at an unprecedented speed. Barriers that have existed for years — whether regulatory, logistical, or scientific — are falling. Join STAT for a four-part digital event series jointly developed and delivered by Harvard Medical School to discuss everything from the rapid deployment of telehealth to the development of drugs and vaccines. The first part took place on May 7 and discussed new biopharma collaborative models for Covid-19. The second part took place on May 14 and discussed telemedicine during the Covid-19 pandemic. The third part took place on May 21 and discussed tech solutions for Covid-19 surveillance and contact tracing.
This series will take place on Zoom, and attendees will be able to both see the discussions live and participate by asking questions. Access to the event is free.
Part 4: The foundations of reopening. May 28 at 1 p.m. ET
- Gilad S. Gordon, M.D., M.B.A, president, ORRA Group; associate clinical professor of medicine, University of Colorado School of Medicine
- Joia Mukherjee, M.D., M.P.H., chief medical officer, Partners in Health; associate professor, Harvard Medical School
- Helen Branswell, senior writer, infectious disease, STAT
- Stanley Y. Shaw, M.D., Ph.D., associate dean for executive education, Harvard Medical School